NXTC Stock Analysis: Buy, Sell, or Hold?
NXTC - NextCure, Inc. Common Stock
$1.81
0.06 (3.43%)
▲
5d:
-8.59%
30d:
-82.25%
90d:
-82.61%
HOLD
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When NXTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NXTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NXTC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NXTC is currently trading at $1.81, which is considered slightly low relative to its 30-day fair value range of $1.62 to $7.28.
Technical Outlook: Technically, NXTC is in a downtrend. The price is currently testing key support at $2.28. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: NXTC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.33 (+968.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NXTC is in a downtrend. The price is currently testing key support at $2.28. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: NXTC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $19.33 (+968.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.62 -
$7.28
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading 968.1% below Wall St target ($19.33)
- CAUTION: Recommendation downgraded due to -8.6% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.62 -
$7.28
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.28
Resistance Level
$7.56
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.22
Wall Street Target
$19.33
(+968.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 24, 2026 9:37 AM ET
Data refreshes hourly during market hours. Next update: 10:37 AM
Data refreshes hourly during market hours. Next update: 10:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NXTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
